All In MedTech

Device Trial Radar · NCT05503199

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Last checked: Nov 20, 2026Latest source record: Apr 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

450

Actual

Start

Oct 1, 2022

Primary completion

Apr 18, 2024

Study completion Apr 18, 2024

Sponsor

Lead sponsor
Deutsches Herzzentrum MuenchenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 16, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ACCESS-TAVI trial is an investigator-initiated, prospective, randomized, multicenter, open-label clinical trial. The objective of the trial is to compare two different vascular closure device strategies for large bore vascular access following transfemoral transcatheter aortic valve implantation with regard to safety and efficacy.

Conditions

  • Aortic Valve Stenosis

Interventions

  • Combination of one Perclose ProGlide or ProStyle (Abbott Vascular) and one Angio-Seal (Terumo).Device

    Combined suture- and plug-based VCD strategy after TF-TAVI.

  • Combination of two ProGlides or ProStyles (Abbott Vascular).Device

    Pure suture-based VCD strategy after TF-TAVI.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major or minor vascular and access-site-related complications or need for additional interventional or surgical procedures related to vascular hemostasis.Time frame: In-hospital, in average three days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Deutsches Herzzentrum München

    Munich, Bavaria, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.